As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a ...

This series of meetings of experts, organized under the auspices of the Standing Committee on Advances and National Security Implications of Transdisciplinary Biotechnology, will bring together ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

New Taipei City, Taiwan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing ...

Pascal Soriot, CEO of AstraZeneca, told China Daily that the company has been deeply rooted in China for decades, and that ...

Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date. This series of meetings of experts, organized under the auspices of ...

HONG KONG--(BUSINESS WIRE)--Reynold Lemkins Group, a leading global investment firm focused on late-stage growth and frontier technologies, announced its significant cornerstone investment in the ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in ...

Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the World SALT LAKE CITY, Nov. 7, 2025 /PRNewswire/ -- Resonant, a Renew Biotechnologies subsidiary ...

CAMBRIDGE, Mass., May 29, 2025 /PRNewswire/ -- RevivBio, a trailblazing biotech company Redefining Biologics and Biosensors development, welcomes Dr. Ron Meeusen to its Board of Directors. Dr. Meeusen ...

Forbes contributors publish independent expert analyses and insights. I write about finance, innovation, climate and sustainability Europe’s next wave of biotech innovation could determine how the ...

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...